Clinical trial
Phase 3 Trial of Litx™ Plus Chemotherapy vs. Chemotherapy Only Treating…
NCT00440310 · Light Sciences Oncology, Industry · Completed
Key facts
| NCT number | NCT00440310 |
|---|---|
| Title | Phase 3 Trial of Litx™ Plus Chemotherapy vs. Chemotherapy Only Treating Colorectal Cancer Patients With Recurrent Liver Metastases |
| Official title | A Multicenter Multinational Phase 3 Randomized Study to Evaluate the Safety and Efficacy of Treating Colorectal Cancer Patients With Recurrent Liver Metastases Using the Litx™ System Plus Chemotherapy as Compared to Chemotherapy Only |
| Lead sponsor | Light Sciences Oncology, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Liver Metastases, Colorectal Neoplasms, Neoplasm Metastasis, Neoplasm Recurrence, Local |
| Intervention type | Device, Drug, Procedure |
| Interventions | Talaporfin sodium, Percutaneous placement of device in liver metastases, Interstitial light emitting diodes, FOLFOX4 regimen, FOLFIRI regimen |
| Enrollment | 483 |
| Start date | Feb 1, 2007 |
| Primary completion | May 1, 2011 |
| Completion | Oct 1, 2011 |
| First posted | Feb 27, 2007 |
| Last update posted | Aug 25, 2015 |
| Countries | Austria, Bosnia and Herzegovina, Croatia, Germany, India, Italy, Latvia, Poland, Romania, Russia, Serbia, Sweden and 1 more |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: